Valneva

Valneva Forward P/E

The Forward P/E Ratio of Valneva (VLA.PA) as of Oct 18, 2026 is -6.85. In the previous year, Forward P/E Ratio was -64.42 — a change of -89.37% (higher).

Forward P/E

-6.85

YoY

-89.37%

Last updated:

Forward P/E Ratio of Valneva is 2025 -6.85 . Forward P/E Ratio of Valneva was 2024 -64.42 . It decreases by -89.37% higher compared to the previous year.

The Valneva Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
241.72 EUR
Jan 1, 2019
-452.40 EUR
Jan 1, 2020
-12.25 EUR
Jan 1, 2021
-10.75 EUR
Jan 1, 2022
-5.51 EUR
Jan 1, 2023
-7.78 EUR
Jan 1, 2024
-64.42 EUR
Jan 1, 2025
-6.85 EUR
The Valneva Forward P/E history
YEARForward P/EYoY
-6.85-89.37%
-64.42+728.19%
-7.78+41.26%
-5.51-48.75%
-10.75-12.30%
-12.25-97.29%
-452.40-287.16%
241.72-451.78%
-68.71+328.36%
-16.04-58.08%
-38.27+27.43%
-30.03—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Forward P/E Ratio of Valneva is -6.85 in 2025.

Forward P/E Ratio of Valneva changed from -64.42 to -6.85, representing a -89.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Valneva since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Valneva with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Valneva

All Key Metrics — Valneva